1-2-azaborine and ethylbenzene

1-2-azaborine has been researched along with ethylbenzene* in 2 studies

Other Studies

2 other study(ies) available for 1-2-azaborine and ethylbenzene

ArticleYear
A Boron Protecting Group Strategy for 1,2-Azaborines.
    Journal of the American Chemical Society, 2017, 10-25, Volume: 139, Issue:42

    Upon reaction with either molecular oxygen or di-tert-butylperoxide in the presence of a simple copper(I) salt and an alcohol, a range of 1,2-azaborines readily exchange B-alkyl or B-aryl moieties for B-alkoxide fragments. This transformation allows alkyl and aryl groups to serve for the first time as removable protecting groups for the boron position of 1,2-azaborines during reactions that are not compatible with the easily modifiable B-alkoxide moiety. This reaction can be applied to synthesize a previously inaccessible BN isostere of ethylbenzene, a compound of interest in biomedical research. A sequence of epoxide ring opening using N-deprotonated 1,2-azaborines followed by an intramolecular version of the boron deprotection reaction can be applied to access the first examples of BN isosteres of dihydrobenzofurans and benzofurans, classes of compounds that are important to medicinal chemistry and natural product synthesis.

    Topics: Benzene Derivatives; Benzofurans; Boron; Boron Compounds

2017
BN/CC isosteric compounds as enzyme inhibitors: N- and B-ethyl-1,2-azaborine inhibit ethylbenzene hydroxylation as nonconvertible substrate analogues.
    Angewandte Chemie (International ed. in English), 2013, Feb-25, Volume: 52, Issue:9

    Good substrate gone bad! BN/CC isosterism of ethylbenzene leads to N-ethyl-1,2-azaborine and B-ethyl-1,2-azaborine. In contrast to ethylbenzene, which is the substrate for ethylbenzene dehydrogenase (EbDH), N-ethyl-1,2-azaborine (see scheme; Fc=Ferricenium tetrafluoroborate) and B-ethyl-1,2-azaborine are strong inhibitors of EbDH. Thus, the changes provided by BN/CC isosterism can lead to new biochemical reactivity.

    Topics: Benzene Derivatives; Boron Compounds; Enzyme Inhibitors; Hydroxylation; Oxidoreductases

2013